David Garcia
Associate Director, Health Economics & Outcomes Research
Expertise:
David Garcia is an Associate Director in the Health Economics & Outcomes Research group at EVERSANA.
After several years of working as a physician in Venezuela, he moved to Canada and completed an MSc in Clinical Epidemiology at Memorial University of Newfoundland, where he contributed to the conduct of several research projects. At EVERSANA, David has been involved in a variety of projects including HTA submissions, development of economic models, feasibility assessments of indirect treatment comparisons, systematic literature reviews, medical communications, peer-reviewed manuscripts and posters, and gap analyses for the development of pharmaceutical products’ value communications.
Articles by David Garcia
Demonstrating the Clinical and Economic Value of Efgartigimod for AChR‑Positive gMG in Canada
Generalized myasthenia gravis (gMG) is a rare autoimmune neuromuscular disease that leads to fluctuating muscle weakness and fatigue, often disrupting daily life. Even with standard therapies, many patients continue to experience persistent symptoms or medication‑related side effects. Chronic immunoglobulin therapy is often used, but it comes with its own challenges, including limited clinical evidence and […]